Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

NCT03871621 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Diabetes Medicines
DRUG: Dapagliflozin

Sponsor

Mackay Memorial Hospital